These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 27323816)

  • 1. Could gut microbiota serve as prognostic biomarker associated with colorectal cancer patients' survival? A pilot study on relevant mechanism.
    Wei Z; Cao S; Liu S; Yao Z; Sun T; Li Y; Li J; Zhang D; Zhou Y
    Oncotarget; 2016 Jul; 7(29):46158-46172. PubMed ID: 27323816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study on clinicopathological features and intestinal microflora changes in colorectal cancer patients born over a nine-year period encompassing three years before and after the Great Chinese famine.
    Li J; Wei Z; Cao S; Tan X; Liu S; Yao Z; Sun T; Li Y; Zhang D; Zhou Y
    Cancer Epidemiol; 2019 Apr; 59():166-172. PubMed ID: 30776583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of the Fusobacterium nucleatum status in colorectal cancers.
    Chen Y; Lu Y; Ke Y; Li Y
    Medicine (Baltimore); 2019 Sep; 98(39):e17221. PubMed ID: 31574832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study.
    Shariati A; Razavi S; Ghaznavi-Rad E; Jahanbin B; Akbari A; Norzaee S; Darban-Sarokhalil D
    Infect Agent Cancer; 2021 Jun; 16(1):41. PubMed ID: 34108031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
    Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
    J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of the gut microbiota on prognosis after surgery for colorectal cancer - a systematic review and meta-analysis.
    Colov EP; Degett TH; Raskov H; Gögenur I
    APMIS; 2020 Feb; 128(2):162-176. PubMed ID: 32017196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gut microbiota: What impact on colorectal carcinogenesis and treatment?].
    Bruneau A; Baylatry MT; Joly AC; Sokol H
    Bull Cancer; 2018 Jan; 105(1):70-80. PubMed ID: 29217301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of bacteria varies between colorectal adenocarcinomas, precursor lesions and non-malignant tissue.
    Bundgaard-Nielsen C; Baandrup UT; Nielsen LP; Sørensen S
    BMC Cancer; 2019 Apr; 19(1):399. PubMed ID: 31035942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 16S rRNA of Mucosal Colon Microbiome and CCL2 Circulating Levels Are Potential Biomarkers in Colorectal Cancer.
    Nardelli C; Granata I; Nunziato M; Setaro M; Carbone F; Zulli C; Pilone V; Capoluongo ED; De Palma GD; Corcione F; Matarese G; Salvatore F; Sacchetti L
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis in Mice via a Toll-Like Receptor 4/p21-Activated Kinase 1 Cascade.
    Wu Y; Wu J; Chen T; Li Q; Peng W; Li H; Tang X; Fu X
    Dig Dis Sci; 2018 May; 63(5):1210-1218. PubMed ID: 29508166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between Bacteroides fragilis and Fusobacterium nucleatum infection and colorectal cancer in Vietnamese patients.
    Nguyen Duy T; Le Huy H; Đao Thanh Q; Ngo Thi H; Ngo Thi Minh H; Nguyen Dang M; Le Huu S; Ngo Tat T
    Anaerobe; 2024 Aug; 88():102880. PubMed ID: 38942229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the intestinal microbiome in colorectal cancer surgery outcomes.
    Lauka L; Reitano E; Carra MC; Gaiani F; Gavriilidis P; Brunetti F; de'Angelis GL; Sobhani I; de'Angelis N
    World J Surg Oncol; 2019 Dec; 17(1):204. PubMed ID: 31791356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients.
    Kunzmann AT; Proença MA; Jordao HW; Jiraskova K; Schneiderova M; Levy M; Liska V; Buchler T; Vodickova L; Vymetalkova V; Silva AE; Vodicka P; Hughes DJ
    Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1891-1899. PubMed ID: 31367996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer.
    Lopez-Siles M; Martinez-Medina M; Surís-Valls R; Aldeguer X; Sabat-Mir M; Duncan SH; Flint HJ; Garcia-Gil LJ
    Inflamm Bowel Dis; 2016 Jan; 22(1):28-41. PubMed ID: 26595550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the NF-κB/HIF-1α signaling pathway in colorectal cancer by tyrosol: a gut microbiota-derived metabolite.
    Guo J; Meng F; Hu R; Chen L; Chang J; Zhao K; Ren H; Liu Z; Hu P; Wang G; Tai J
    J Immunother Cancer; 2024 Sep; 12(9):. PubMed ID: 39343509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of
    Guo S; Li L; Xu B; Li M; Zeng Q; Xiao H; Xue Y; Wu Y; Wang Y; Liu W; Zhang G
    Clin Chem; 2018 Sep; 64(9):1327-1337. PubMed ID: 29914865
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Gethings-Behncke C; Coleman HG; Jordao HWT; Longley DB; Crawford N; Murray LJ; Kunzmann AT
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):539-548. PubMed ID: 31915144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour-associated and non-tumour-associated microbiota: Addendum.
    Flemer B; Herlihy M; O'Riordain M; Shanahan F; O'Toole PW
    Gut Microbes; 2018 Jul; 9(4):369-373. PubMed ID: 29420132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiome associated with APC gene mutation in patients with intestinal adenomatous polyps.
    Liang S; Mao Y; Liao M; Xu Y; Chen Y; Huang X; Wei C; Wu C; Wang Q; Pan X; Tang W
    Int J Biol Sci; 2020; 16(1):135-146. PubMed ID: 31892851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.